- Dubai Health Care City, Dubai, UAE
With the development of the intragastric balloon system comes a weight loss aid which is used in conjunction with a supervised diet and behavior modification program, and can help you achieve the health and aesthetic benefits associated with weight loss.
The Balloon Program
The Balloon consists of a soft expandable balloon made of a soft material. Inserted in the stomach and filled with sterile saline solution or with air, it is inserted for six months or one year. The Balloon fills space in the stomach thereby procuring a feeling of satiety. It helps you make the necessary behavioral and habit changes to achieve your weight loss goals.
The Elipse™ is the world’s first swallowed and excreted IGB. It does not require endoscopy or anesthesia and hence costs a fraction of other IGBs. Moreover, the Elipse™ is designed to self-empty and pass safely through the gastrointestinal tract, mitigating the risk of patients lost to follow-up.
– Allurion’s flagship product—the Elipse™— is such an intragastric balloon. It works by filling the – stomach, slowing digestion, and teaching portion control.
– Patients swallow it during a brief office visit and – months later – pass it into the toilet.
– No surgery. No endoscopy. No anesthesia.
Saleh Clinic is the Middle East centre of reference in the POSE technique.
Weare the first team in the Middle East to perform this new incision less weight loss procedure to decrease the capacity of a patient’s stomach, first case done on september 2012.
Primary Obesity Surgery, Endoluminal, (POSE) is safe endoscopic treatment of obesity that does not require incisions. It helps suppress hunger, so patients can more effectively control their portions and lose weight. POSE, which has an exemplary safety record in over 3,500 procedures, is designed for the patient who is around 20 to 40 pounds( 9 to 18 kg) overweight and highly unlikely, unwilling or unable to consider bariatric surgery.
It offers the opportunity to move into the procedural space with this patient population, that represents ~50% of the population in the Middle East.
The operation enables oral reduction of stomach capacity, without the need for incision. In this way, the patient presents prompt satiety and ingests less food. The procedure consists of forming and suturing folds in the stomach to reduce its size and capacity for distension.
Its advantages are:
– Reduction of postsurgical pain
– Reduced risk of infection
– Absence of external scars
– Faster recovery
– Shorter hospital stays or outpatient surgery
In which cases can it be used?
It is especially recommended in patients with a body mass index (BMI) from 28 to 35 kg/m2 in whom diet treatments have failed.
What are the different phases of the treatment?
After the surgery, the patients is taken to the recovery room for approximately one hour to recover from the anaesthesia before being transferred to his or her room. In our unit, we advise spending another night in the clinic in order to provide the patient with care in case of pain or any surgery-related complication. The patient is discharged the next morning and is able to live a relatively normal life 24 hours after the operation.
For the first month, the patient has to follow a basically liquid diet, graduating to a semi-soft and soft diet until he or she can follow a solid diet six weeks after the surgery. It is not advisable to gain weight in the first two months.
Weight loss begins after the first week and the mean weight loss achieved in our clinic is 10-15 kg in the first 6 months and a maintained weight after a year.
New indications for the POSE procedure
– Lower BMI, such as BMI 28-35 meaning those who to lose more than 10 kg, who have special needs or special interest in POSE
– Patients who have lost weight using a balloon and fear regaining that weight when the balloon is removed
– Patients who have regained weight after balloon, or did not lose much weight after balloon and wish an alternative without invasiveness